Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
121,00 € 0,00 (0,00%)
2026-06-04
CENA AKCJI
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionFiduciary Trust Co
Latest Disclosed Ownership51,557 shares
Latest Disclosed Value $ 7,875,259
Fiduciary Trust Co reports 7.30% decrease in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On May 15, 2026 - Fiduciary Trust Co filed a 13F-HR form disclosing ownership of 51,557 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $6,625,074 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 55,618 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of -7.30% during the quarter. The current value of the position is $6,238,397 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 51,557 -4,061 -7.30 7,875 2.70 0.0542
2026-02-13 2025-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 55,618 -2,215 -3.83 7,668 3.40 0.0872
2025-11-14 2025-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 57,833 -162 -0.28 7,416 5.69 0.0840
2025-08-14 2025-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 57,995 -1,428 -2.40 7,018 5.93 0.0863
2025-05-15 2025-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 59,423 9,865 19.91 6,624 37.37 0.0868
2025-02-14 2024-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 49,558 -399 -0.80 4,822 -16.08 0.0637
2024-11-14 2024-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 49,957 600 1.22 5,746 9.36 0.0803
2024-08-14 2024-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 49,357 -2,877 -5.51 5,255 4.00 0.0789
2024-05-14 2024-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 52,234 -96 -0.18 5,053 -4.37 0.0775
2024-02-12 2023-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 52,330 -698 -1.32 5,284 -2.18 0.0883
2023-11-14 2023-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 53,028 -545 -1.02 5,401 -0.09 0.0988
2023-08-01 2023-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 53,573 -1,751 -3.16 5,406 6.23 0.0953
2023-05-15 2023-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 55,324 -1,742 -3.05 5,090 -1.70 0.0944
2023-02-14 2022-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 57,066 -1,319 -2.26 5,177 16.65 0.1007
2022-11-14 2022-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 58,385 569 0.98 4,438 -9.21 0.0960
2022-08-12 2022-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 57,816 -870 -1.48 4,888 -5.09 0.1030
2022-05-12 2022-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 58,686 -3,473 -5.59 5,150 -5.28 0.0923
2022-02-14 2021-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 62,159 -5,264 -7.81 5,437 -1.40 0.0894
2021-11-12 2021-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 67,423 -9,221 -12.03 5,514 -21.15 0.0981
2021-08-16 2021-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 76,644 -14,884 -16.26 6,993 -10.62 0.1353
2021-05-19 2021-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 91,528 -1,760 -1.89 7,824 -11.18 0.1588
2021-01-26 2020-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 93,288 -9,155 -8.94 8,809 -1.11 0.1836
2020-11-13 2020-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 102,443 -1,459 -1.40 8,908 -1.84 0.2099
2020-08-13 2020-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 103,902 -1,543 -1.46 9,075 4.38 0.2246
2020-05-15 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 105,445 -1,124 -1.05 8,694 -13.84 0.2523
2020-02-04 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 106,569 -3,185 -2.90 10,091 5.80 0.2353
2019-11-12 2019-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 109,754 3,282 3.08 9,538 -1.89 0.2394
2019-08-14 2019-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 106,472 1,663 1.59 9,722 -3.52 0.2551
2019-05-07 2019-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 104,809 -3,921 -3.61 10,077 8.01 0.2709
2019-01-29 2018-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 108,730 -397 -0.36 9,330 -0.77 0.2858
2018-11-13 2018-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 109,127 -2,635 -2.36 9,402 11.37 0.2639
2018-08-03 2018-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 111,762 -12,390 -9.98 8,442 -15.89 0.2556
2018-05-07 2018-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 124,152 3,016 2.49 10,037 -1.31 0.3101
2018-01-29 2017-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 121,136 -1,543 -1.26 10,170 -3.44 0.3023
2017-11-02 2017-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 122,679 -3,601 -2.85 10,532 -0.09 0.3241
2017-08-09 2017-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 126,280 -4,932 -3.76 10,541 8.17 0.3231
2017-05-15 2017-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 131,212 -11,664 -8.16 9,745 -6.36 0.2978
2017-02-14 2016-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 142,876 -18,592 -11.51 10,407 -18.38 0.3372
2016-11-14 2016-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 161,468 -3,656 -2.21 12,750 -6.42 0.4366
2016-08-12 2016-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 165,124 -17,696 -9.68 13,624 2.87 0.4786
2016-05-16 2016-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 182,820 182,820 13,244 0.4682
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.